Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platform

Lisa D. MacDonald; Alecia MacKay; Valarmathy Kaliaperumal; Genevieve Weir; Andrea Penwell; Rajkannan Rajagopalan; Joanne M. Langley; Scott Halperin; Marc Mansour; Marianne M. Stanford

doi:10.1080/21645515.2017.1375637

Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platform

Lisa D. MacDonald, Alecia MacKay, Valarmathy Kaliaperumal, Genevieve Weir, Andrea Penwell, Rajkannan Rajagopalan, Joanne M. Langley, Scott Halperin, Marc Mansour, Marianne M. Stanford

科研成果: 期刊稿件 › 文章 › 同行评审

4 引用（Scopus）

源语言	英语
页（从-至）	59-66
页数	8
期刊	Human Vaccines and Immunotherapeutics
卷	14
期	1
DOI	https://doi.org/10.1080/21645515.2017.1375637
出版状态	已出版 - 1月 2 2018

!!!ASJC Scopus Subject Areas

免疫学和过敏症
药理学
免疫学

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

访问文件

10.1080/21645515.2017.1375637

其它文件与链接

引用此

MacDonald, L. D., MacKay, A., Kaliaperumal, V., Weir, G., Penwell, A., Rajagopalan, R., Langley, J. M., Halperin, S., Mansour, M., & Stanford, M. M. (2018). Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platform. Human Vaccines and Immunotherapeutics, 14(1), 59-66. https://doi.org/10.1080/21645515.2017.1375637

MacDonald, LD, MacKay, A, Kaliaperumal, V, Weir, G, Penwell, A, Rajagopalan, R, Langley, JM , Halperin, S, Mansour, M & Stanford, MM 2018, 'Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platform', Human Vaccines and Immunotherapeutics, 卷 14, 号码 1, 页码 59-66. https://doi.org/10.1080/21645515.2017.1375637

@article{08343025a4a64718a4a73c88abd98be5,

title = "Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platform",

keywords = "RSV, adjuvant, alum, depot, hypersensitivity, vaccine",

author = "MacDonald, {Lisa D.} and Alecia MacKay and Valarmathy Kaliaperumal and Genevieve Weir and Andrea Penwell and Rajkannan Rajagopalan and Langley, {Joanne M.} and Scott Halperin and Marc Mansour and Stanford, {Marianne M.}",

note = "Publisher Copyright: {\textcopyright} 2018 Immunovaccine Inc. {\textcopyright} 2018, {\textcopyright} Immunovaccine Inc.",

year = "2018",

month = jan,

day = "2",

doi = "10.1080/21645515.2017.1375637",

language = "English",

volume = "14",

pages = "59--66",

journal = "Human Vaccines and Immunotherapeutics",

issn = "2164-5515",

publisher = "Landes Bioscience",

number = "1",

}

TY - JOUR

T1 - Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platform

AU - MacDonald, Lisa D.

AU - MacKay, Alecia

AU - Kaliaperumal, Valarmathy

AU - Weir, Genevieve

AU - Penwell, Andrea

AU - Rajagopalan, Rajkannan

AU - Langley, Joanne M.

AU - Halperin, Scott

AU - Mansour, Marc

AU - Stanford, Marianne M.

PY - 2018/1/2

Y1 - 2018/1/2

KW - RSV

KW - adjuvant

KW - alum

KW - depot

KW - hypersensitivity

KW - vaccine

UR - http://www.scopus.com/inward/record.url?scp=85032686706&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032686706&partnerID=8YFLogxK

U2 - 10.1080/21645515.2017.1375637

DO - 10.1080/21645515.2017.1375637

M3 - Article

C2 - 28933663

AN - SCOPUS:85032686706

SN - 2164-5515

VL - 14

SP - 59

EP - 66

JO - Human Vaccines and Immunotherapeutics

JF - Human Vaccines and Immunotherapeutics

IS - 1

ER -

Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platform

!!!ASJC Scopus Subject Areas

联合国可持续发展目标

访问文件

其它文件与链接

指纹

引用此